Q4 2022 Holdings
Filed 2023-02-02 | 14 holdings | $61.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Aerovate Therapeutics Inc. | Common Stock | 008064107 | $17.7M | 603,762 | 28.9% |
| Centessa Pharmaceuticals plc(CNTA) | Sponsored ADS | 152309100 | $9.1M | 2,937,615 | 14.9% |
| PMV Pharmaceuticals, Inc.(PMVP) | Common Stock | 69353Y103 | $8.6M | 989,232 | 14.1% |
| Dice Therapeutics Inc. | Common Stock | 23345J104 | $8.4M | 268,346 | 13.7% |
| ionQ, Inc.(IONQ) | Common Stock | 46222L108 | $4.1M | 1,177,597 | 6.6% |
| Cyteir Therapeutics, Inc. | Common Stock | 23284P103 | $4.1M | 2,459,572 | 6.6% |
| Vor Biopharma Inc. | Common Stock | 929033108 | $2.5M | 374,714 | 4.1% |
| Prime Medicine, Inc.(PRME) | Common Stock | 74168J101 | $2.3M | 121,255 | 3.7% |
| Graphite Bio(GRPH) | Common Stock | 38870X104 | $1.3M | 406,308 | 2.2% |
| Precision BioSciences, Inc. | Common Stock | 74019P108 | $1.3M | 1,123,913 | 2.2% |
| Selecta Biosciences, Inc.(SELBUSD) | Common Stock | 816212104 | $974.7K | 862,543 | 1.6% |
| eFFECTOR Therapeutics, Inc. | Common Stock | 28202V108 | $438.6K | 1,025,697 | 0.7% |
| Spero Therapeutics, Inc.(SPRO) | Common Stock | 84833T103 | $430.9K | 249,070 | 0.7% |
| Homology Medicines, Inc. | Common Stock | 438083107 | $80.6K | 64,000 | 0.1% |